Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 29,800 KRW
Change Today +1,700 / 6.05%
Volume 493.0K
003220 On Other Exchanges
Symbol
Exchange
Korea SE
As of 2:11 AM 07/6/15 All times are local (Market data is delayed by at least 15 minutes).

daewon pharmaceutical co ltd (003220) Snapshot

Open
27,900
Previous Close
28,100
Day High
32,050
Day Low
27,700
52 Week High
07/6/15 - 32,050
52 Week Low
08/8/14 - 9,905
Market Cap
511.7B
Average Volume 10 Days
342.8K
EPS TTM
923.81
Shares Outstanding
17.2M
EX-Date
12/29/14
P/E TM
32.3x
Dividend
142.86
Dividend Yield
0.48%
Current Stock Chart for DAEWON PHARMACEUTICAL CO LTD (003220)

Related News

No related news articles were found.

daewon pharmaceutical co ltd (003220) Related Businessweek News

No Related Businessweek News Found

daewon pharmaceutical co ltd (003220) Details

Daewon Pharm. Co. Ltd., a pharmaceutical company, manufactures and sells medicines in South Korea and internationally. The company offers vitamin supplements; and medicines for circulatory, respiratory, antibiotic, mental neurological, chemotherapy, and psychoneurosis uses, as well as antipyretic, analgesic, anti-inflammatory, gastrointestinal, antimicrobial, cardiovascular, neuromuscular, endocrine, and other drugs. Its principal products include Oramin-F Soft cap., a multivitamin; Pelubi tablet for pain relief; Aquafol inj. for the anti-exogenous infectious bacteria; Megex-I susp., a medicine supplementing subalimentation of cancer patients; Trigel susp./tab. for the therapy of gastritis and duodenal ulcer; and Metran cap. for use in mammalian physiology. The company was founded in 1958 and is headquartered in Seoul, South Korea.

Founded in 1958

daewon pharmaceutical co ltd (003220) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

daewon pharmaceutical co ltd (003220) Key Developments

Daewon Pharmaceutical Co. Ltd., Annual General Meeting, Mar 27, 2015

Daewon Pharmaceutical Co. Ltd., Annual General Meeting, Mar 27, 2015., at 10:00 Korea Standard Time. Location: Factory conference room Hyangnam, crew Pharmaceutical Co., Ltd.. Agenda: To consider the consolidated financial statements for the period from January 01, 2014 to December 31, 2014; to consider appropriation of retained earnings (draft) approval of cash dividend; to consider the appointment of director and other non-emergency patients outside directors; to consider the appointment of audit committee; and to consider the approval of remuneration ceiling.

Daewon Pharmaceutical Co. Ltd., Annual General Meeting, Mar 14, 2014

Daewon Pharmaceutical Co. Ltd., Annual General Meeting, Mar 14, 2014., at 10:00 Korea Standard Time. Location: hyangnameup Pharmaceutical Corporation , Hwaseong-si. Agenda: To approve the consolidated financial statements for the year ended December 31, 2013; to approve dividend; to consider election of Directors; to consider appointment of Audit Committee; and to approve directors' remuneration limit.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
003220:KS 29,800.00 KRW +1,700

003220 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 003220.
View Industry Companies
 

Industry Analysis

003220

Industry Average

Valuation 003220 Industry Range
Price/Earnings 27.6x
Price/Sales 2.6x
Price/Book 3.7x
Price/Cash Flow 27.7x
TEV/Sales 2.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAEWON PHARMACEUTICAL CO LTD, please visit www.daewonpharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.